Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

10981.  Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease. Am J Gastroenterol. 2004 Jul;99(7):1316-20.

10982.  Ambrosetti A, Zanotti R, Pattaro C, Lenzi L, Chilosi M, Caramaschi P, Arcaini L, Pasini F, Biasi D, Orlandi E, D'Adda M, Lucioni M, Pizzolo G. Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Br J Haematol. 2004 Jul;126(1):43-9.

10983.  Ashish K, Gupta S, Gupta P. Co-infection of HBV and HCV in patients of liver disease – a study in North India. Indian Med Gaz 2004; 138(2): 57-62.

10984.  Bacon BR. Chronic hepatitis C and normal ALT: considerations for treatment. Am J Gastroenterol. 2004 Sep;99(9):1706-7.

10985.  Bollens D, Guiguet M, Tangre P, Rollinat L, Rachline A, Meynard JL, Girard PM, Benlian P, Meyohas MC. Major hypertriglyceridemia in HIV-infected patients on antiretroviral therapy: a role of the personal and family history. Infection. 2004 Aug;32(4):217-21.

10986.  Bruden DL, McMahon BJ, Hennessy TW, Christensen CJ, Homan CE, Williams JL, Sullivan DG, Gretch DR, Cagle HH, Bulkow LR. Estimating the date of hepatitis C virus infection from patient interviews and antibody tests on stored sera. Am J Gastroenterol. 2004 Aug;99(8):1517-22.

10987.  Chawla Y. Management of hepatitis C in immunocompetent patients. Gastroenterol Today 2002; 6(4): 195-8.

10988.  Di Bisceglie AM. Screening for hepatocellular carcinoma: being old is not all bad. Am J Gastroenterol. 2004 Aug;99(8):1477-8.

10989.  Grabhorn E, Schulz A, Helmke K, Hinrichs B, Rogiers X, Broering DC, Burdelski M, Ganschow R. Short- and long-term results of liver transplantation in infants aged less than 6 months. Transplantation. 2004 Jul 27;78(2):235-41.

10990.  Hajeer AH, Memish ZA, Al-Knawy BA. Laboratory diagnosis of Hepatitis C virus infection. A change to common practice. Saudi Med J. 2004 Jul;25(7):827-9. 

10991.  Ito K, Fujita T, Shimizu A, Koike S, Sasaki K, Matsunaga N, Hibino S, Yuhara M. Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions. AJR Am J Roentgenol. 2004 Sep;183(3):699-705.

10992.  Mancini C, Pisani G, Azzi A, Luisa Zerbini M, Gentili G, Mario Bisso G; MS participants. Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy. J Clin Virol. 2004 Aug;30(4):313-9.

10993.  Nagpal AK. Viral markers and selection for treatment in chronic hepatitis B and C. Gastroenterol Today 2002; 6(4):183-7.

10994.  Park SA, Heo K. Prominent cerebellar symptoms with unusual magnetic resonance imaging findings in acquired hepatocerebral degeneration. Arch Neurol. 2004 Sep; 61(9): 1458-60.

10995.  Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, Messous D, Thibault V, Benhamou Y, Moussalli J, Ratziu V. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem. 2004 Aug;50(8):1344-55. 

10996.  Sakhuja P, Malhotra V, Gondal R, Sarain SK, Thaku V. Histological profile of liver disease in patients with dual hepatitis B and C virus infection. Indian J Path Microbiol 2003; 46(4):555-8.

10997.  Saltik-Temizel IN, Kocak N, Ozen H, Demir H. Serum hyaluronic acid concentrations in children with cirrhosis. Indian J Gastroenterol. 2004 Jul-Aug;23(4):129-30.

10998.  Shidrawi R, Ali Al-Huraibi M, Ahmad Al-Haimi M, Dayton R, Murray-Lyon IM. Seroprevalence of markers of viral hepatitis in Yemeni healthcare workers. J Med Virol. 2004 Aug;73(4):562-5.

10999.  Sum SS, Wong DK, Yuen MF, Yuan HJ, Yu J, Lai CL, Ho D, Zhang L. Real-time PCR assay using molecular beacon for quantitation of hepatitis B virus DNA. J Clin Microbiol. 2004 Aug;42(8):3438-40.

11000.  Toivola DM, Ku NO, Resurreccion EZ, Nelson DR, Wright TL, Omary MB. Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology. 2004 Aug;40(2):459-66.

11001.  Wang N, Gao XQ, Han JX. Simultaneous detection of HBV and HCV by multiplex PCR normalization. World J Gastroenterol. 2004 Aug 15;10(16):2439-43.

11002.  Wightman F, Walters T, Ayres A, Bowden S, Bartholomeusz A, Lau D, Locarnini S, Lewin SR. Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of Lamivudine-resistant hepatitis B virus strains. J Clin Microbiol. 2004 Aug;42(8):3809-12.

11003.  Williams J. Guidelines to determine who should be tested for hepatitis C. Nurs Times. 2004 Jul 13-19;100(28):28-9. Review.

11004.  Wu XZ, Chen D, Zhao LS, Yu XH, Wei M, Zhao Y, Fang Q, Xu Q. Early diagnosis of bacterial and fungal infection in chronic cholestatic hepatitis B. World J Gastroenterol. 2004 Aug 1;10(15):2228-31.

11005.  Yuan HJ, Yuen  MF, Wong DK, Sum SS, Lai CL. Clinical evaluation of the digene hybrid capture II test and the COBAS AMPLICOR monitor test for determination of hepatitis B virus DNA levels. J Clin Microbiol. 2004 Aug;42(8):3513-7.

11006.  Zechini B, Pasquazzi C, Aceti A. Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression. Eur J Gastroenterol Hepatol. 2004 Sep;16(9):891-6.

Pathogenesis:

11007.  Almond LM, Boffito M, Hoggard PG, Bonora S, Raiteri R, Reynolds HE, Garazzino S, Sinicco A, Khoo SH, Back DJ, Di Perri G. The relationship between nevirapine plasma concentrations and abnormal liver function tests. AIDS Res Hum Retroviruses. 2004 Jul;20(7):716-22.

11008.  Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, Marchi S, Ferrannini E.  Thyroid disorders in chronic hepatitis C. Am J Med. 2004 Jul 1;117(1):10-3.

11009.  Choi KJ, Lim CW, Yoon MY, Ahn BY, Yu YG. Quantitative analysis of the interaction between the envelope protein domains and the core protein of human hepatitis B virus. Biochem Biophys Res Commun. 2004 Jul 2;319(3):959-66.

11010.  de Lalla C, Galli G, Aldrighetti L, Romeo R, Mariani M, Monno A, Nuti S, Colombo M, Callea F, Porcelli SA, Panina-Bordignon P, Abrignani S, Casorati G, Dellabona P. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol. 2004 Jul 15;173(2):1417-25.

11011.  Eroglu C, Leblebicioglu H, Gunaydin M, Turan D, Sunbul M, Esen S, Sanic A. Distinguishing hepatitis B virus (HBV) genotype D from non-D by a simple PCR. J Virol Methods. 2004 Aug;119(2):183-7.

11012.  Furione M, Maserati R, Gatti M, Baldanti F, Cividini A, Bruno R, Gerna G, Mondelli MU. Dissociation of serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus and treated with antiretroviral drugs. J Clin Microbiol. 2004 Jul;42(7):3012-6.

11013.  Gonzalez-Calvin JL, Gallego-Rojo F, Fernandez-Perez R, Casado-Caballero F, Ruiz-Escolano E, Olivares EG. Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis. J Clin Endocrinol Metab. 2004 Sep;89(9):4325-30.

11014.  Habu D, Shiomi S, Tamori A, Takeda T, Tanaka T, Kubo S, Nishiguchi S. Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. JAMA. 2004 Jul 21;292(3):358-61.

11015.  Jardi R, Rodriguez-Frias F, Buti M, Schaper M, Valdes A, Martinez M, Esteban R, Guardia J.  Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA. Hepatology. 2004 Jul;40(1):133-9.

11016.  Lee J, Shin MK, Lee HJ, Yoon G, Ryu WS. Three novel cis-acting elements required for efficient plus-strand DNA synthesis of the hepatitis B virus genome. J Virol. 2004 Jul;78(14):7455-64.

11017.  Liu J, Guo Y, Xue CF, Li YH, Huang YX, Ding J, Gong WD, Zhao Y. Effect of vector-expressed siRNA on HBV replication in hepatoblastoma cells. World J Gastroenterol. 2004 Jul 1;10(13):1898-901.

11018.  Messerini L, Novelli L, Comin CE. Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma. J Clin Pathol. 2004 Aug;57(8):867-71.

11019.  Murakami H, Akbar SM, Matsui H, Horiike N, Onji M. Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin Exp Immunol. 2004 Sep;137(3):559-65.

11020.  Ni Q, Chen Z, Yao HP, Yang ZG, Liu KZ, Wu LL. Inhibition of human La protein by RNA interference downregulates hepatitis B virus mRNA in 2.2.15 cells. World J Gastroenterol. 2004 Jul 15;10(14):2050-4.

11021.  Ovejero C, Cavard C, Perianin A, Hakvoort T, Vermeulen J, Godard C, Fabre M, Chafey P, Suzuki K, Romagnolo B, Yamagoe S, Perret C. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Hepatology. 2004 Jul;40(1):167-76.

11022.  Pemberton PW, Aboutwerat A, Smith A, Burrows PC, McMahon RF, Warnes TW. Oxidant stress in type I autoimmune hepatitis: the link between necroinflammation and fibrogenesis? Biochim Biophys Acta. 2004 Aug 4;1689(3):182-9.

11023.  Saez A, Losa M, Lo Iacono O, Lozano C, Alvarez E, Pita L, Garcia-Monzon C. Diagnostic and prognostic value of virologic tests in vertical transmission of hepatitis C virus infection: results of a large prospective study in pregnant women. Hepatogastroenterology. 2004 Jul-Aug;51(58):1104-8.

11024.  Soffredini R, Rumi MG, Parravicini ML, Ronchi G, Del Ninno E, Russo A, Colombo M. Serum levels of hepatitis C virus core antigen as a marker of infection and response to therapy. Am J Gastroenterol. 2004 Sep;99(9):1738-43.

11025.  Tomer Y, Villanueva R. Hepatitis C and thyroid autoimmunity: is there a link? Am J Med. 2004 Jul 1;117(1):60-1. 

11026.  Valenti L, De Feo T, Fracanzani AL, Fatta E, Salvagnini M, Arico S, Rossi G, Fiorelli G, Fargion S. Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients. Alcohol Alcohol. 2004 Jul-Aug;39(4):276-80.

11027.  Wu KL, Lu SN, Changchien CS, Chiu KW, Kuo CH, Chuah SK, Liu JW, Lin MC, Eng HL, Chen SS, Lee CM, Chen CL. Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome. Am J Trop Med Hyg. 2004 Aug;71(2):125-8.

11028.  Yang G, Pevear DC, Collett MS, Chunduru S, Young DC, Benetatos C, Jordan R. Newly synthesized hepatitis C virus replicon RNA is protected from nuclease activity by a protease-sensitive factor(s). J Virol. 2004 Sep;78(18):10202-5.

11029.  Zhao L, Mou DC, Leng XS, Peng JR, Wang WX, Huang L, Li S, Zhu JY. Expression of cancer-testis antigens in hepatocellular carcinoma. World J Gastroenterol. 2004 Jul 15;10(14):2034-8.

Vaccines:

11030.  Cutts FT, Hall AJ. Vaccines for neonatal viral infections: hepatitis B vaccine. Expert Rev Vaccines. 2004 Aug;3(4):349-52. Review.

11031.  Eriksen EM, Perlman JA, Miller A, Marcy SM, Lee H, Vadheim C, Zangwill KM, Chen RT, DeStefano F, Lewis E, Black S, Shinefield H, Ward JI. Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the vaccine safety datalink project. Pediatr Infect Dis J. 2004 Jul;23(7):656-62.

11032.   Rubinstein E. Vaccination and autoimmune diseases: the argument against. Isr Med Assoc J. 2004 Jul;6(7):433-5. 

11033.  Vijaya Kumar V, Hari R, Parthiban R, Mehta J, Thyagarajan SP. Evaluation of Immunogenicity and safety of genevac b: a new recombinant hepatitis b vaccine in comparison with engerix b and shanvac b in healthy adults. Indian Journal of Medical Microbiology. 2004 Jan; 22(1): 34-8

Therapy:

11034.  D'Souza R, Foster GR. Diagnosis and treatment of chronic hepatitis B. J R Soc Med. 2004 Jul;97(7):318-21. Review. 

11035.  Lahousen T, Hegenbarth K, Ille R, Lipp RW, Krause R, Little RR, Schnedl WJ. Determination of glycated hemoglobin in patients with advanced liver disease. World J Gastroenterol. 2004 Aug 1;10(15):2284-6.

11036.  Matthews SC, Paulus MP, Dimsdale JE. Contribution of functional neuroimaging to understanding neuropsychiatric side effects of interferon in hepatitis C. Psychosomatics. 2004 Jul-Aug;45(4):281-6. Review.

11037.  McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. 2004 Sep;287(3):G497-502. Review.

11038.  Morisco F, Vitaglione P, Carbone A, Stingo S, Scarpati S, Ascione A, Marmo R, Fogliano V, Caporaso N. Tomato-based functional food as interferon adjuvant in HCV eradication therapy. J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S118-20.

11039.  Stark JJ. Prevention of hepatocellular carcinoma. Ann Intern Med. 2004 Jul 6;141(1):77; author reply 77-8. 

11040.  Theurl I, Zoller H, Obrist P, Datz C, Bachmann F, Elliott RM, Weiss G. Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3. J Infect Dis. 2004 Aug 15;190(4):819-25. 

11041.  Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D'Elia R, Zanesco L, Cesaro S.  Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer. 2004 Aug 1;101(3):635-41.